A61K 47/6898
Using avidin- or biotin-conjugated antibodies
Official title: {using avidin- or biotin-conjugated antibodies}
A61K47/6898 (Using avidin- or biotin-conjugated antibodies) appears on 136 US grants and 133 published applications in this corpus.
Search patents in A61K- Granted patents
- 136
- Published applications
- 133
- Assignees
- 100
- Inventors
- 292
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 10 | 0 |
| 1998 | 7 | 0 |
| 1999 | 10 | 0 |
| 2000 | 5 | 0 |
| 2001 | 8 | 3 |
| 2002 | 9 | 12 |
| 2003 | 5 | 16 |
| 2004 | 2 | 10 |
| 2005 | 7 | 8 |
| 2006 | 5 | 10 |
| 2007 | 4 | 6 |
| 2008 | 2 | 2 |
| 2009 | 7 | 4 |
| 2010 | 3 | 5 |
| 2011 | 4 | 2 |
| 2012 | 1 | 3 |
| 2013 | 4 | 3 |
| 2014 | 3 | 5 |
| 2015 | 1 | 2 |
| 2016 | 1 | 7 |
| 2017 | 6 | 2 |
| 2018 | 1 | 3 |
| 2019 | 2 | 5 |
| 2020 | 4 | 7 |
| 2021 | 3 | 5 |
| 2022 | 1 | 1 |
| 2023 | 3 | 5 |
| 2024 | 3 | 3 |
| 2025 | 2 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Multifunctional immunotherapeutic monoclonal antibody complexes and conjugates7 Apr 2026US 12,594,341 B2
- Artificial antigen-presenting cells and methods for producing and using the same25 Nov 2025US 12,478,688 B2Indiana University Research and Technology Corporation
- Method of administering a nanoparticle7 Oct 2025US 12,433,956 B2Kawasaki Institute of Industrial Promotion
- Compositions and methods for non-myeloablative conditioning26 Nov 2024US 12,152,080 B2Children's Medical Center Corporation
- Conjugate of biotin-modified dimer and phthalocyanine dye15 Oct 2024US 12,115,223 B2Savid Therapeutics Inc.
- Multifunctional immunotherapeutic monoclonal antibody complexes and conjugates16 Jul 2026US 2026/0199506 A1
- Novel copolymer19 Feb 2026US 2026/0048140 A1Kowa Company, Ltd.
- Biotin orthogonal streptavidin system2 Oct 2025US 2025/0304705 A1
- Beads for targeted signal delivery1 May 2025US 2025/0135027 A1Rubhu Biologics, Inc.
- Fusion protein of vhh antibody and streptavidin mutant14 Nov 2024US 2024/0374747 A1Savid Therapeutics Inc.
Most cited
By later US patents
- Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments180US 5,716,595 AImmunomedics, Inc. · 1998
- Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy173US 6,096,289 AImmunomedics, Inc. · 2000
- Interactive molecular conjugates150US 5,998,588 AUniversity of Washington · 1999
- Pretargeting methods and compounds125US 6,217,869 B1NeoRx Corporation · 2001
- Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy117US 6,387,350 B2Immunomedics, Inc. · 2002